Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.

J Cardiovasc Magn Reson · 2011 · PMC3148987 · PMID 21733147

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significancep = 0.051so close (0.05 < p ≤ 0.1)

The reduction in RVESV over 12 months was also related to the baseline ESV value with borderline significance (p = 0.051), and there was a significant difference between drugs favouring deferiprone by a mean of 4.5 mL more than patients on deferoxamine (95% CI 1.2 to 7.8 mL; p = 0.009).

also in 4,327 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.